Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use E-cigarettes and Cannabis (Co-Tox Study)
NCT ID: NCT07167225
Last Updated: 2025-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
150 participants
OBSERVATIONAL
2025-04-03
2028-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Young Adult Tobacco/Nicotine and Cannabis Co-use
NCT06239350
PK/PD of Vaping THC-containing Liquids vs. Smoked Cannabis
NCT06055231
Effect of Cannabis on E-Cigarette Use Behavior
NCT06609109
THC Crossover Study
NCT04429568
Switching to a Vaping Device: Evaluating Risk Reduction Among Quitline Treatment Failures
NCT03502200
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To evaluate differences in self-reported nicotine and cannabis use behaviors and biomarkers of exposure to toxicants and carcinogens by product use status, to generate effect sizes required to calculate sample sizes needed for a larger study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
E-cigarette consumers
Predominant e-cigarette consumers
Effectiveness of different recruitment approaches
Subjects will asked which type of recruitment material they've seen when completing the screening survey
Choice of study completion locations
subjects will choose location when coordinator calls to schedule appointment
E-cigarette dependence Scale
A 22-item questionnaire measuring e-cigarette dependence. Higher scores indicate greater dependence.
Cannabis consumers
Predominant cannabis consumers
Effectiveness of different recruitment approaches
Subjects will asked which type of recruitment material they've seen when completing the screening survey
Choice of study completion locations
subjects will choose location when coordinator calls to schedule appointment
Cannabis Engagement Assessment
Self reported measure of current cannabis use that contains 30 questions assessing quantity, frequency of use and method of consumption in the past 30 days.
e-cigarette -cannabis coconsumers
Consumers who use both e-cigarettes and cannabis .
Effectiveness of different recruitment approaches
Subjects will asked which type of recruitment material they've seen when completing the screening survey
Choice of study completion locations
subjects will choose location when coordinator calls to schedule appointment
Cannabis Engagement Assessment
Self reported measure of current cannabis use that contains 30 questions assessing quantity, frequency of use and method of consumption in the past 30 days.
E-cigarette dependence Scale
A 22-item questionnaire measuring e-cigarette dependence. Higher scores indicate greater dependence.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Effectiveness of different recruitment approaches
Subjects will asked which type of recruitment material they've seen when completing the screening survey
Choice of study completion locations
subjects will choose location when coordinator calls to schedule appointment
Cannabis Engagement Assessment
Self reported measure of current cannabis use that contains 30 questions assessing quantity, frequency of use and method of consumption in the past 30 days.
E-cigarette dependence Scale
A 22-item questionnaire measuring e-cigarette dependence. Higher scores indicate greater dependence.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to read and write in English.
* Participants must fall into one of the following groups (based on self-report):
* Predominant e-cigarette consumer: defined as using nicotine-containing e-cigarettes daily for the past six months but not having used other nicotine containing products more than weekly or cannabis products for the past month.
* Predominant cannabis consumer: defined as using cannabis at least 3x/week for the past six months in any form, including smoking, vaping, and oral use, with no more than weekly use of any nicotine or tobacco products.
* E-cigarette-cannabis co-consumers: defined as daily use of nicotine e-cigarettes and use of cannabis at least 3x/week, including smoking, vaping, and oral use, for at least the past six months, with no use of other nicotine containing products more than weekly.
* No self-reported diagnosis of kidney disease (current, or within the past year prior to the study visit).
* Participants must understand the voluntary nature of this study and sign a written informed consent form before proceeding with study activities.
Exclusion Criteria
* Currently pregnant or breastfeeding (female participants).
* Unwilling or unable to follow protocol requirements
18 Years
25 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Roswell Park Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Danielle Smith, PhD
Role: PRINCIPAL_INVESTIGATOR
Roswell Park
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Roswell Park Comprehensive Cancer Center
Buffalo, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
ASK RPCI
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
I-4235024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.